Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi-metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Large-scale testing (Phase 3)Active Not RecruitingNCT02542293
What this trial is testing

Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)

Who this might be right for
Non Small Cell Lung Carcinoma NSCLC
AstraZeneca 953
Large-scale testing (Phase 3)Study completedNCT02395016
What this trial is testing

Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Biotech Pharmaceutical Co., Ltd. 90
Early research (Phase 1)Study completedNCT03897036
What this trial is testing

Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)

Who this might be right for
Carcinoma, Basal Cell
Senhwa Biosciences, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT04143711
What this trial is testing

Study of DF1001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Dragonfly Therapeutics 270
Testing effectiveness (Phase 2)Study completedNCT04866134
What this trial is testing

ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 85
Not applicableEnded earlyNCT05592483
What this trial is testing

An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 78
Large-scale testing (Phase 3)Study completedNCT00522951
What this trial is testing

SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study

Who this might be right for
Brain Metastases
Bayer 165
Not applicableActive Not RecruitingNCT06762470
What this trial is testing

Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma

Who this might be right for
Histopathological Diagnosis of Nasopharyngeal CarcinomaPatients with Nasopharyngeal Carcinoma Without Distant Metastases After AJCC/UACC 8th Edition
Jiangxi Provincial Cancer Hospital 325
Testing effectiveness (Phase 2)Study completedNCT02336451
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges

Who this might be right for
ALK-positive Non-small Cell Lung Cancer
Novartis Pharmaceuticals 156
Early research (Phase 1)Study completedNCT00051779
What this trial is testing

An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerMetastasis
Chugai Pharma USA
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188
What this trial is testing

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Who this might be right for
KRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more
Novartis Pharmaceuticals 344
Early research (Phase 1)Study completedNCT05639751
What this trial is testing

PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancers+1 more
Prelude Therapeutics Incorporated 135
Very early researchStudy completedNCT01660529
What this trial is testing

Multi-peptide Vaccine With Basilixumab for Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Abramson Cancer Center at Penn Medicine 10
Large-scale testing (Phase 3)UnknownNCT03778541
What this trial is testing

HFSRT With Concurrent TMZ for Large BMs

Who this might be right for
Brain MetastasesChemotherapyRadiotherapy
Chinese Academy of Medical Sciences 224
Not applicableNot Yet RecruitingNCT06493448
What this trial is testing

Prospective Observational Cohort Study

Who this might be right for
Gastric CancerLiver Metastases
Lin Chen 1,326
Not applicableUnknownNCT02776878
What this trial is testing

A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST

Who this might be right for
Gastrointestinal Stromal Tumor
Peking University Cancer Hospital & Institute 57
Testing effectiveness (Phase 2)UnknownNCT02976740
What this trial is testing

SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy

Who this might be right for
Lung Cancer Metastatic
The First Affiliated Hospital of Xiamen University 48
Large-scale testing (Phase 3)Active Not RecruitingNCT06018337
What this trial is testing

DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

Who this might be right for
Metastatic Breast Cancer
DualityBio Inc. 541
Not applicableUnknownNCT03626818
What this trial is testing

The Impact of Neurocognitive Function in Patients With Multiple Brain Metastases Receiving Whole Brain Radiation Therapy

Who this might be right for
Brain Metastases
Guangdong Association of Clinical Trials 125
Next Page